New Investigative Therapy for Methylmalonic Acidemia and Propionic Acidemia is Making Regulatory Progress
source: pixabay.com

New Investigative Therapy for Methylmalonic Acidemia and Propionic Acidemia is Making Regulatory Progress

Fast Track Designation and Rare Pediatric Disease Designation have just been awarded from the FDA to HemoShear Therapeutics. This designation was given to their new investigative therapy for propionic acidemia…

Continue Reading New Investigative Therapy for Methylmalonic Acidemia and Propionic Acidemia is Making Regulatory Progress
Company Receives Clearance to Conduct Trial for Propionic and Methylmalonic Acidemia
source: pixabay.com

Company Receives Clearance to Conduct Trial for Propionic and Methylmalonic Acidemia

According to a press release from HemoShear Therapeutics, the company has recently received official clearance from the US Food and Drug Administration (FDA) in regards to its Investigational New Drug…

Continue Reading Company Receives Clearance to Conduct Trial for Propionic and Methylmalonic Acidemia
New Partnership Will Develop Gene Therapy for Propionic Acidemia
lisichik / Pixabay

New Partnership Will Develop Gene Therapy for Propionic Acidemia

According to a story from Scimex, the Children's Medical Research Institute in Sydney, Australia, has recently agreed to a new partnership with LogicBio Therapeutics, a biotechnology company from Boston, MA.…

Continue Reading New Partnership Will Develop Gene Therapy for Propionic Acidemia
Close Menu